Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.

by Myles Starr

Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.

by Jon Kelvey

November is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.

At age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.

by Karon Warren

Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.

by Eve Spiegel

It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.

by Abigail M. Johnston

Forward Look

Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.

by Tara Haelle

Forward Look

Adding an anthracycline to taxane chemotherapy regimens can reduce recurrence risk in early-stage breast cancer, but side effects also factor into treatment decisions.

by Kris Conner

Forward Look

A clinical trial affirms the value of a procedure that preserves more tissue in early-stage lung cancer patients.

by Ashley P. Taylor

Forward Look

Pretzel-shaped device delivers sustained doses of chemotherapy to the bladder

by Leah Lawrence